OBJECTIVE: To use magnetic resonance imaging (MRI) to validate estimates of muscle and adipose tissue (AT) in lower limb sections obtained by dual-energy X-ray absorptiometry (DXA) modelling. DESIGN: MRI measurements were used as reference for validating limb muscle and AT estimates obtained by DXA models that assume fat-free soft tissue (FFST) comprised mainly muscle: model A accounted for bone hydration only; model B also applied constants for FFST in bone and skin and fat in muscle and AT; model C was as model B but allowing for variable fat in muscle and AT. SUBJECTS: Healthy men (n 8) and women (n 8), ages 41 ± 62 y; mean (s.d.) body mass indices (BMIs) of 28.6 (5.4) kgam 2 and 25.1 (5.4) kgam 2 , respectively. MEASUREMENTS: MRI scans of the legs and whole body DXA scans were analysed for muscle and AT content of thigh (20 cm) and lower leg (10 cm) sections; 24 h creatinine excretion was measured. RESULTS: Model A overestimated thigh muscle volume (MRI mean, 2.3 l) substantially (bias 0.36 l), whereas model B underestimated it by only 2% (bias 0.045 l). Lower leg muscle (MRI mean, 0.6 l) was better predicted using model A (bias 0.04 l, 7% overestimate) than model B (bias 0.1 l, 17% underestimate). The 95% limits of agreement were high for these models (thigh, AE 20%; lower leg, AE 47% ). Model C predictions were more discrepant than those of model B. There was generally less agreement between MRI and all DXA models for AT. Measurement variability was generally less for DXA measurements of FFST (coef®cient of variation 0.7 ± 1.8%) and fat (0.8 ± 3.3%) than model B estimates of muscle (0.5 ± 2.6%) and AT (3.3 ± 6.8%), respectively. Despite strong relationships between them, muscle mass was overestimated by creatinine excretion with highly variable predictability. CONCLUSION: This study has shown the value of DXA models for assessment of muscle and AT in leg sections, but suggests the need to re-evaluate some of the assumptions upon which they are based.
Introduction
Dual-energy X-ray absorptiometry (DXA) can provide measurements of fat, bone mineral content (BMC) and fat-free soft tissue (FFST) in the whole body and in individual body segments. As FFST in limbs is assumed to consist mainly of skeletal muscle, a model has been suggested (model A 1 ) that predicts muscle mass from appendicular FFST with a correction factor for the assumed hydration of bone. However, model A does not take into account the fact that some fat is present within muscle tissue and that there is FFST associated with extra-muscular tissues such as skin and adipose tissue (AT); the latter may consist of about 20% or more FFST in lean subjects 2, 3 but less (down to about 15%) in the obese. 4 Also, there is no provision in this model for estimates of AT to be obtained from DXA measurements. Preliminary calculations have also suggested that AT would be substantially overestimated if it was derived directly from DXA fat measurements, whatever assumptions were applied to account for the proportion of fat in AT (from about 60% to 85%). Therefore, an alternative model has been suggested (model B 5 that predicts muscle and AT mass from the basic information on limb components provided by DXA, in conjunction with anthropometric estimates of limb skin mass and assumptions about the proportions of fat and FFST in the skin and skeletal mass. The comparative validity of both these DXA models has yet to be evaluated against an established reference method. This is especially important in view of the uncertainties surrounding those assumptions concerning soft tissue mesurements, particularly where the proportions of fat and FFST over bone have been extrapolated from measurements that do not contain bone, which is an inherent limitation in DXA methodology, 6 even before additional modelling techniques are applied. In addition, neither model has yet been applied to the assessment of discrete sections of proximal or distal limb segments which is available as the`sub-region analysis package' with the Hologic QDR 1000aW. Furthermore, there is also a paucity of information regarding reproducibility of muscle and AT predictions using DXA models.
The primary aim of this study was to use magnetic resonance imaging (MRI) as an appropriate reference method 7 in order to achieve four main objectives: (a) to determine the value of DXA measurements of FFST for predicting muscle mass; (b) to validate the use of existing DXA models in predicting muscle and AT for de®ned sections of thigh and lower leg (calf); (c) to consider and assess the potential value of alternative modelling (model C) which takes into account the variability in fat content of muscle and AT according to the degree of body fatness as predicted by body mass index (BMI); and (d) to determine measurement variability in estimates of limb and limb section muscle and AT. A secondary aim was to compare MRI estimates of muscle content of limb sections or DXA estimates of limb sections, limbs and whole body with those predicted from creatinine excretion rates 8 ± 11 obtained from 24 h urine collections, where completeness of collection was veri®ed by use of the marker para-amino benzoic acid (PABA 12 ).
Methods
Sixteen healthy subjects volunteered for the study: men (n 8) of age range 43 ± 62 (median 50) y, mean weight 89. 6 2 . Details of these same subjects also appear in a separate report 13 concerning the development of a bio-electrical impedance method of assessing limb section muscle mass and its validation against MRI reference data, some of which is also used here (data concerning the left leg). Food consumption for the period leading up to the study was ad libitum. All measurements were obtained in the morning after an overnight fast.
Body weight (kg) was measured using a Sauter Type E1210 electronic scales (Todd Scales, Suffolk, UK) and standing height (m) was measured with a wall-mounted stadiometer. BMI was determined as Quetelet's index (kgam 2 ).
All volunteers were subjected to MRI of the whole leg which was analysed for muscle and AT content of 20 cm sections of thigh and 10 cm sections of calf, as described by Fuller et al. 13 As the MRI analysis was unable to distinguish AT from skin, estimates of AT were obtained by subtracting estimates of skin volume from MRI measurements of AT plus skin. Skin volume was itself obtained from section surface area, calculated from MRI circumference measurements at the extremes and mid-points of the sections, and skin thicknesses (assumed to be 0.16 cm for men and 0.12 cm for women).
Each subject underwent whole-body DXA on a Hologic QDR 1000aW and the data was analysed using the software Enhanced whole body V5.61. Thigh and calf regions were, as far as possible, delineated in exactly the same way as the MRI sections (above) and analysed for BMC, FFST (recorded as`lean' on the printout of results provided by Hologic) and fat using the`sub-region analysis package' available on the DXA instrument. Estimates of skin surface area and volume were obtained from anthropometric circumference measurements at the same points as identi®ed for MRI circumference measurements. 13 A 24 h urine collection using 5 g boric acid as preservative was obtained from each subject and the volume recorded. Completeness of collection was con®rmed by recovery of the administered marker, PABA. 12 Urine creatinine was determined using the standard alkaline-picrate Jaffe Â reaction (Roche; catalogue no. 07-3667-8 for use with the COBAS BIO 1 ).
A sub-set of four volunteers, two men and two women in whom BMI ranged from 21 to 28 kgam 2 , was subjected to a second DXA assessment, shortly after the ®rst, to establish the extent of variability in measurements of muscle and AT in thigh and calf sections and whole legs (right and left), and of muscle in the whole body, which was estimated from appendicular (arms and legs) muscle mass. 1, 5 
Calculations
Where appropriate, tissue mass and volume were interconverted using an assumed density of 1.0414 kgal for muscle and 0.916 kgal for AT. 2 Daily 24 h creatinine excretion was used to estimate muscle mass assuming that 1 g (8.85 mmol) urinary creatinine corresponds to either 17 kg muscle 14 or other values ranging from 16.2 to 17.9 kg. 8 An alternative prediction equation 9 was also used:
Skeletal muscle mass kg 14X4 Â creatinine g 3X6X
Estimates of limb and limb section composition provided by DXA were incorporated into models to predict muscle mass. Limb (or section) AT mass in men 1.256 total limb (or section) mass 7 0.0950 skin mass (from anthropometry) 7 2.054 bone ash mass 7 1.284 FFST mass.
Model C: Model B was modi®ed slightly to take into account potential variability in the fat content of both muscle and AT according to degree of body fatness. Limited data from a number of sources, including cadaver studies (some of which were summarised in the Report of Task Group on Reference Man) 2,3 and computed tomography (CT) scans 15 were used to formulate equations relating, linearly, the mean amounts of fat in muscle or AT that were assumed to correspond to mean BMIs of 21 kgam 2 for lean subjects and 36 kgam 2 for the obese: for muscle, 2.2% in lean 2 and 10.8% in the obese; 15 and for AT, 75% in lean 16, 17 Ð or even lower 3 Ð and 85% in obese subjects. 4 In addition, because of uncertainty regarding the relationship of fat in muscle or AT to BMI, alternative values were also modelled (e.g. 60 ± 84% fat in AT and 2.5 ± 9.4% fat in muscle) that were based on a possible range of values suggested by the above sources. The BMI of each subject in the study was used to estimate individual fat content of muscle and AT from these equations. Such estimates were then applied as variables to model C, instead of the constant values incorporated in model B. 5 DXA estimates of limb muscle mass 5 were extrapolated to whole-body muscle mass assuming that total limb (arms and legs) muscle contributes 75% to whole body muscle. 2 An alternative value of 52%, obtained by calculation from data derived from CT, 18 was also used to estimate muscle mass of the whole body.
Statistics
The strength of relationships between variables was assessed using Pearson`s correlation coef®cient (r). The bias and 95% limits of agreement between the MRI reference method and alternative prediction techniques (reference minus prediction), and the relationships between the size of estimate and difference between methods were assessed. 19 Coef®cient of repeatability (C r ) was assessed as twice the standard deviation (s.d.) of the differences (d ) between repeats, 19, 20 
Ethical approval
This study was approved by the local Ethical Committees of Addenbrooke's Hospital and the Dunn Clinical Nutrition Centre, and informed consent was obtained from each subject. ) in leg sections and whole leg, and wholebody muscle (assuming that limb muscle contributes either 75% or 52% to whole body muscle, see above). There was no evidence of asymmetry in tissue composition associated with limb dominance.
Results
A strong relationship was found between MRI assessments of muscle in all leg sections and DXA estimates of FFST for these same sections: left thigh, r 0.95; right thigh, r 0.98; left calf, r 0.93; and right calf, r 0.97. Table 3 demonstrates the extent of agreement between MRI and DXA methods for FFST, muscle and AT in thigh and calf sections of each leg for all subjects and for men and women separately. This table also indicates where the bias is in¯uenced by the magnitude of measurement but, with the exception of the right calf and right thigh in women, Difference between methods becomes more positive with increasing magnitude of measurement (signi®cance, P`0.05).
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Difference between methods becomes more negative with increasing magnitude of measurement (signi®cance, P`0.05).
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which just reached signi®cance (P`0.05) there was no apparent in¯uence of the proportion of fat or AT on the difference between methods for any of these sections.
Results for the comparison of model C with MRI are not shown; ®rst, because of the large number of predictions of muscle and AT obtained by applying many different values to the fat content of these tissues; and, second, because none of the manipulations actually improved predictability over that of model B. Despite the bias being fairly small, and apparently slightly less than that for model B on a couple of occasions, the 95% limits of agreement were always greater, substantially so in a majority of cases. This is illustrated by two examples of the prediction of muscle in the right thigh and right calf (for all subjects in the study), when values were modelled for fat in muscle of 2.2% and 10.8% and fat in AT of 75% and 85%, for lean and obese, respectively. In the right thigh, the bias was only slightly worse for model C than for model B ( 7 0.07 vs 0.05 l), but the 95% limits of agreement were substantially greater ( AE 0.6 vsAE 0.35 l). In the right calf, although the bias was slightly better for model C than for model B (0.06 vs 0.09 l), the 95% limits of agreement were also substantially greater ( AE 0.17 vs AE 0.11 l).
All urine collections were considered to be complete since a mean of 94% of the administered dose of PABA was recovered; all collections were in excess of the 85% recovery recommended as indicative of completeness of collection. 12 Twenty-four hour creatinine excretion rates were 2.02 (s.d. 0.31) gad for men and 1.38 (s.d. 0.25) gad for women, and strong relationships were observed between these and MRI assessments of thigh section muscle (r 0.93), calf section muscle (r 0.84) or summed limb section muscle (r 0.94). However, despite the strong relationship (r 0.92 for whole body muscle) between creatinine excretion rates and DXA estimates of muscle mass, use of the assumption that muscle in the limbs contributes 75% to whole body muscle resulted in a large bias ( 7 8.9 kg for all subjects) with substantial ( AE 7.3 kg) 95% limits of agreement between DXA model B and estimates by the creatinine excretion method (assuming that 1 g urinary creatinine corresponds to 17 kg muscle). Use of the alternative assumption, that limb muscle contributes just 52% to the whole body (calculated from Chowdhury et al 18 ), reduced the bias considerably (to 7 1.92 kg for all subjects), but increased (to AE 12.5 kg) the 95% limits of agreement (Table 4) . In contrast, use of alternative equations to predict muscle mass from creatinine excretion rates 8, 9 affected the estimates by less than AE 1 kg, with similar limits of agreement for all predictions. Table 5 shows the extent of measurement variability for each limb section, legs and whole body. In general, the DXA assessments of FFST and fat were less variable than estimates of muscle or AT (DXA model B), respectively: AT estimates were relatively more variable than those for muscle tissue.
Discussion
The importance of reliable information concerning muscle mass and AT, both clinically and in general, has been well emphasised. 21, 22 In view of this, the potential of various models for predicting muscle and AT in sections of the lower limb, based on DXA measurements but differing in their levels of 1 That model B provided better estimates of muscle volume than model A, or that both models offered improved estimates over the simple DXA FFST prediction, is not surprising since the contribution of FFST to the skeleton, skin and AT was partially taken into account with model A and fully accounted for in model B. Similarly, in the calf (mean volume by MRI, 0.59 l), the overestimation of muscle (mean 18%), obtained by simply assuming that DXA FFST consisted entirely of muscle, was overcome in part by using model A (mean overestimate 7%). In contrast to the thigh, however, use of model B resulted in a substantial underestimation (17%) of muscle in the calf. Clearly, such ®ndings have implications for the success of these DXA modelling techniques because they are based on certain assumptions that may be confounded by biological differences in muscle or AT composition that may be present between genders or individuals or between different regions in the same individual.
Inconsistencies between methods due to biological variaton may arise from differences in the thickness of skin, the amount and composition of AT associated with skin (in particular the hypodermis), 5 the contribution and distribution of fat in both AT and muscle and the relative amounts of interstitial AT. 7 Fat may account for as little as 54% of AT in lean subjects 3 up to about 85%. 3, 4 Furthermore, the fat content of muscle may range from 2% in lean subjects 2 to about 11% in the obese, 15 and may be substantially higher in muscle wasting diseases such as pseudohypertrophic Duchenne muscular dystrophy, where fat appears to replace muscle. 23 The use of model C was an attempt to overcome differences in the fat content of muscle and AT, which might be associated with increasing degrees of adiposity, by using BMI as an index. However, this model did not improve predictions of either muscle or AT over that of model B. Gender differences may be one of the reasons behind the relatively greater 95% limits of agreement between model C (all variables considered) and MRI estimates compared with model B, despite the occasional lower bias. Model B accounts for the difference between men and women in the fat content of muscles, but assumes a constant value that is more akin to lean subjects than fatter individuals, whereas model C assumes a variability in fat content of muscle and AT that is dependent on BMI, but takes no account of differences between genders. The inconsistent level of agreement with the MRI reference method between thigh and calf (Table  3) suggests that regional differences may also exist. DXA models were originally derived from averages of the whole limb, 1, 5 so that local differences in tissue composition or distribution could invalidate their use in limb sections. For example, the contribution of FFST to skeletal mass may vary between the thigh, containing one bone (the femur), and the calf, which contains two Ð the tibia and the ®bula. Skin thickness may vary according to its location. 5 These considerations could imply the need for modi®cation of the models when applied to different limb sections.
There are technical differences between methods that may also have some bearing on the discrepancies observed in this study. For example, dif®culties exist in reproducing exactly the same section delineation for both MRI and DXA analyses. The resolution is limited in both methods. Because each MRI slice covers a 1 cm width, the error in locating the knee joint space and then the exact lower leg section limits could be up to 0.5 cm, 2.5% of the thigh and 5% of the calf section lengths. Couple this with the likelihood of slightly greater error due to the limitations of the DXA subregion analysis, in which line spacing on the DXA image is 1.303 cm, and the potential exists for signi®cant discrepancies to occur between methods. Speci®c dif®culties exist with MRI analysis as there is some overlap in lines of tissue demarcation caused by pixels that include two tissue types, and the extent of error created may depend on the size of these pixels which can be different between individual measurements. Furthermore, during MRI analysis, adjustments are made to allow for variation in signal throughout the volume scanned, 13 and this may also contribute some degree of uncertainty to estimates of tissue content. Similarly, there are some well-established dif®culties in obtaining valid DXA measurements of fat and FFST. For example, soft tissue estimates for areas that include pixels containing bone are extrapolated from the average soft tissue composition of pixels that do not. 6 In addition, the different manufacturers of DXA instruments apply inconsistent assumptions to their raw attenuation measurements in order to obtain fat and FFST. 6 Estimates of muscle and AT obtained by the DXA models will clearly be invalid if based on erroneous measurements.
The good measurement repeatability demonstrated previously for MRI analysis 13 is probably due to the objective nature of the computerised analysis package used, which involves region growing techniques. All that is required from the observer is that individual tissues are ®rst identi®ed and seeded, which clearly minimises the possibility of subjective variability (CV`1%). 13 Although delineation of the whole leg from the trunk for DXA assessments is subjective in nature, the relatively large size of the leg components coupled with some observer experience ensures good measurement precision (for example CV for leg muscle, 1.2%), which is similar to that shown previously. 5 In contrast, location of limb sections using the DXA sub-region package, as in this study, is more objective, being determined by calculation of distances from the easily identi®able knee joint space. Therefore, despite their small size, repeatability of Assessment of limb muscle NJ Fuller et al thigh and calf section measurements using DXA is also reasonably good (Table 5) . However, although estimates of muscle and AT (DXA Model B) are fairly consistent on a group basis (small bias) compared with MRI (Table 3) , their precision is not as good as for the basic DXA assessments (regional mass, FFST, fat and BMC; 5 Table 5 ), because errors associated with DXA and anthropometric measurements (circumferences for estimating skin) are inevitably propagated by the modelling.
Finally, although there are strong relationships between 24 h creatinine excretion and muscle mass (sectional, regional and whole body), it is of some concern that there is poor agreement (bias and 95% limits of agreement are both relatively large) between the DXA model and creatinine estimates of whole-body muscle mass (Table 4 ). This apparent lack of agreement is not attributable to variability in 24 h urine collections, as their completeness was veri®ed by recovery of the administered PABA marker (see results). The possibility that there is some variability in creatinine excretion rates attributable to meat in the diet was minimised, but not entirely excluded, by the use of prediction equations 8, 9 that are speci®c to the ad libitum diets consumed by the subjects prior to the study period. Therefore, such ®ndings indicate the need to review, not only the assumed values for the amount of creatinine excreted per unit of muscle, 11 but also the contribution of the limbs to whole-body muscle mass because of the considerable discrepancy between the values of 75% 2 and 52% (calculated from CT).
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DXA modelling has potential value for clinical applications, especially for assessing longitudinal changes because of its relatively good precision. Although the more complex model B has greater predictability in the thigh than the alternatives, model A is apparently better in the calf. Once such anomalies have been fully resolved, DXA models may prove to be of real value in the management of wasting diseases and in assessing the effects of nutrients or drugs during nutritional repletion or weight loss. For example, DXA modelling of muscle and AT may be used in conjunction with its ability to assess regional, especially waist and hip, fat distribution to monitor the effects of weight loss during treatment for obesity. It may also be used to monitor the nutritional status of HIV patients receiving protease inhibitor therapy in which lypodystrophy is evident 24, 25 and where changes in the quantities and distribution of FFST and fat between limbs and trunk have been observed, but not yet quanti®ed in terms of muscle or AT.
In summary, this study has indicated both the value and limitations of DXA modelling for estimating muscle and AT content of proximal and distal sections of the lower limb.
